Meta-Analysis of the Safety of JAK-STAT inhibitors in Dermatology

This systematic review with meta-analysis examines the risk of major adverse cardiovascular events, venous thromboembolism, serious adverse events, and tolerability of systemic Janus kinase –signal transducer and activation of transcription (JAK-STAT) compared with placebo in those with a dermatologic indication.
Source: JAMA Dermatology - Category: Dermatology Source Type: research